Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Leadsynbio Technology

Explore full profile

Innovative synthetic biology solutions for efficient R&D and manufacturing of advanced bioproducts

ChinaFounded 2015Biotech & Life Sciences
Valuation $250–500M Last recorded · 2023
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Suzhou Leadsynbio Technology and the history behind them.

About Suzhou Leadsynbio Technology

LeadSynBio is a biotechnology startup that specializes in the research, development, and application of synthetic biology technology. The company was founded by a team of experienced professionals who have returned from overseas, including renowned scientists and experts from prestigious research institutions such as UCLA and UC Berkeley.

The company operates in the biotechnology market, serving clients in the agriculture and animal husbandry industries, as well as the nutrition and healthcare sectors. They use biotechnology to transform traditional chemical synthesis processes, aiming to create greener and more economical agrochemical products. This approach aligns with the development concept of green agriculture, which is focused on sustainable and environmentally friendly farming practices.

LeadSynBio also works to improve the quality of products in the animal husbandry industry through technological innovation. By enhancing breeding efficiency, they contribute to the sustainable development of China's animal husbandry industry.

In the nutrition and healthcare sectors, LeadSynBio uses biosynthesis to produce raw materials. This method reduces dependence on natural resources and provides products with better natural quality. Biosynthesis is a process that uses biological systems to produce chemicals, which can be more sustainable and less harmful to the environment than traditional methods.

The company's business model revolves around the R&D and manufacturing of innovative products. Their team of biologists, chemists, data scientists, and software/hardware engineers work together to optimize workflows and data flows, aiming to increase efficiency.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
China
Open positions
1
Dealroom signal
20.0/100
Industry
Health, Food
Sub-industry
BioTechnology, AgriTech, Innovative Food
Sector
Biotech & Life Sciences, Biotechnology, Biomaterials, Synthetic Biology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Links
Website

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Aug 2023 $28M $275M Lilly Asia Ventures · Sherpa Venture Partners ↗
SERIES COther financing Dec 2021 $55M $220M Lilly Asia Ventures · GF Qianhe ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Suzhou Leadsynbio Technology website traffic

Latest recorded traffic for Suzhou Leadsynbio Technology is 510 monthly website visits, up 1600% over the last three months.

Latest monthly visits510 3-month web change+1600%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Chobe Capital
  • Guangdong Lianjing Investment Group

Series A4 investors entered at this stage

  • Yuexiu Industrial Fund
  • Oriza Holdings
  • Zhejiang Bangjie Holding Group
  • Asia Green Fund

Series B and later6 investors entered at this stage

  • Lilly Asia Ventures
  • GF Qianhe
  • HosenCare Brothers
  • Chasing Financial
  • Hillhouse Capital
  • Sherpa Venture Partners

Other known investors1 additional known investor

  • University of California, Los Angeles
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Leadsynbio Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Leadsynbio Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.